Table of Content

Joint health has become an important category within the nutraceutical industry, driven by growing consumer interest in mobility, active ageing, sports performance and long-term musculoskeletal wellbeing. For nutraceutical manufacturers, this has created demand for evidence-based joint health ingredients that can be incorporated into capsules, tablets, sachets, powders and combination formulations.

Among these ingredients, undenatured Type II collagen has attracted particular attention because its proposed mechanism differs from that of conventional hydrolysed collagen peptides.

Hydrolysed collagen is primarily supplied as smaller collagen-derived peptides, often at gram-level serving sizes. Undenatured Type II collagen, in contrast, is designed to retain important aspects of the native collagen structure and is generally used at much lower doses. Its proposed mechanism involves oral tolerance and immune modulation, rather than simply supplying amino acids or collagen peptides.

For formulation teams, understanding this distinction is essential when selecting an ingredient, determining dosage, evaluating clinical evidence and designing a joint health product.

What Is Undenatured Type II Collagen?

Type II collagen is the predominant collagen associated with articular cartilage. Unlike hydrolysed collagen, undenatured Type II collagen is processed under conditions intended to preserve its native structural characteristics.

This structural integrity is important because the proposed biological activity of undenatured Type II collagen is associated with specific collagen epitopes that can interact with the immune system through the gut-associated lymphoid tissue.

Research suggests that orally administered Type II collagen can induce a phenomenon known as oral tolerance, in which exposure to an antigen through the gastrointestinal tract can lead to a regulated immune response rather than an inflammatory response.

For B2B manufacturers, this means that an undenatured Type II collagen ingredient should not be evaluated simply on the basis of its total protein content. The preservation of its native structure is a key part of its intended functionality.

How Does Undenatured Type II Collagen Work?

The mechanism of action is one of the most important differences between undenatured Type II collagen and conventional collagen peptides.

1. Interaction with the gut-associated immune system

Following oral consumption, undenatured Type II collagen reaches the gastrointestinal tract. Certain collagen structures can interact with immune cells associated with the gut-associated lymphoid tissue, including areas such as the Peyer’s patches.

Preclinical research suggests that Type II collagen can be taken up by antigen-presenting cells and presented to T cells, promoting the generation of regulatory T cells.

2. Development of oral tolerance

These regulatory pathways are associated with oral tolerance, an immune mechanism that helps prevent excessive immune responses to antigens encountered through the digestive tract.

Research has identified regulatory cytokines including TGF-β and IL-10 as part of the pathways involved in Type II collagen oral tolerance.

3. Modulation of inflammatory pathways

The resulting regulatory immune response may help moderate processes associated with joint inflammation. This is why undenatured Type II collagen is being investigated as a nutraceutical approach for supporting joint comfort and function. Importantly, this mechanism is different from the simple nutritional role of collagen peptides.

For product developers, this distinction has practical implications:

Hydrolysed collagen: collagen-derived peptides and nutritional peptide-based approach

Undenatured Type II collagen: preserved structural epitopes and oral tolerance immune-modulatory approach

Why Does “Undenatured” Matter in Type II Collagen Ingredients?

The term undenatured is not simply a marketing description.Processing conditions can affect the structure of Type II collagen. Excessive heat, aggressive processing or other conditions that disrupt the native structure may alter the molecular characteristics relevant to its proposed mechanism.

A 2023 review of undenatured Type II collagen highlighted the importance of factors such as source, degree of denaturation, processing conditions, pH, temperature and formulation environment in determining the properties and activity of the ingredient.

For ingredient buyers, this means supplier qualification should go beyond:

“How much collagen does the ingredient contain?”

The more relevant questions are:

  • Is the collagen Type II?
  • Is it genuinely undenatured?
  • How is structural integrity assessed?
  • What processing conditions are used?
  • Is there evidence supporting biological activity?

These questions are particularly important when developing a clinically positioned joint health formulation.

Clinical Evidence for Undenatured Type II Collagen

Undenatured Type II collagen has a clinically investigated low-dose positioning, but formulation claims should always be aligned with the specific ingredient, study population and regulatory requirements of the target market.

Unstergen® Clinical Study: Product-Specific Evidence

A study published in the International Journal of Research in Orthopaedics in 2025 evaluated Unstergen®, an undenatured chicken Type II collagen ingredient from Titan Biotech Limited.

The proof-of-concept trial involved 48 adults with osteoarthritis and followed a randomized, double-blind, placebo-controlled study design.

Participants received:

  • 40 mg/day Unstergen®
  • Placebo
  • Once daily
  • For 90 days

The researchers assessed WOMAC, pain numerical rating scale, quality of life and global rating of change, with X-ray assessment conducted in a subgroup of 12 participants.

The Unstergen® group demonstrated:

  • 20.39% reduction in WOMAC score
  • 37.77% reduction in pain NRS
  • 90.32% of subjects reporting improvement in quality of life
  • 87.50% of the evaluated X-ray subgroup showing marked improvement

No adverse event was attributed to Unstergen® during the study period.

For B2B communication, this study can provide product-specific evidence for Unstergen®, but it should not be generalized to every Type II collagen ingredient.

That distinction is important when developing scientifically responsible ingredient marketing.

What Is the Typical Dosage of Undenatured Type II Collagen?

One of the most commercially interesting characteristics of undenatured Type II collagen is its low-dose application. Several clinical studies have investigated approximately 40 mg/day of undenatured Type II collagen for joint health. The 2015 multicenter clinical study used 40 mg/day, while the recent review of knee osteoarthritis studies also identified 40 mg/day as the commonly studied dose.

Formulating for Different Joint Health Segments

Undenatured Type II collagen can potentially fit several nutraceutical product concepts. Healthy ageing The Unstergen® clinical study similarly evaluated 40 mg/day for 90 days.

This creates an important formulation advantage.

Compared with many joint health ingredients that require gram-level quantities, a 40 mg serving can be accommodated relatively easily in:

  • Hard capsules
  • Softgel combinations
  • Tablets
  • Stick packs
  • Sachets
  • Multi-ingredient joint health formulations

However, manufacturers should not automatically assume that 40 mg/day is appropriate for every Type II collagen ingredient.
Dosage should be based on:

Ingredient identity, structural integrity, clinical evidence, intended claim, target population and regulatory requirements.

Undenatured Type II Collagen vs Hydrolysed Collagen

One of the most common formulation questions is whether undenatured Type II collagen can simply be replaced by hydrolysed collagen.
The answer is not necessarily.

Feature Undenatured Type II Collagen Hydrolysed Collagen
Structure Native/undenatured structure intended to be retained Broken down into smaller peptides
Primary positioning Joint health and oral tolerance Collagen peptide nutrition
Typical dosage Often studied at low mg levels Commonly used at gram levels
Mechanism Proposed immune tolerance mechanism Peptide/amino acid-based mechanisms
Source Commonly chicken cartilage for Type II Fish, bovine, porcine and other sources
Formulation focus Structural integrity and biological activity Solubility, taste, molecular weight and peptide profile
Key quality concern Preservation of native structure Hydrolysis degree and molecular-weight profile

This distinction should be reflected in both technical documentation and marketing communication.

Key Formulation Considerations for Nutraceutical Manufacturers

1. Dosage form

Because undenatured Type II collagen is generally used at a low dosage, capsules and tablets are particularly convenient formats. For example, a formulation could combine Type II collagen with other joint-support ingredients without significantly increasing capsule fill requirements.

2. Combination formulations

Undenatured Type II collagen may be considered alongside ingredients such as:

  • Glucosamine
  • Chondroitin
  • MSM
  • Hyaluronic acid
  • Boswellia extracts
  • Vitamin C
  • Minerals

However, the presence of multiple ingredients does not automatically mean that their mechanisms are synergistic.
Each combination should be evaluated for:

  • Compatibility
  • Stability
  • Dosage
  • Sensory characteristics
  • Regulatory status

3. Processing temperature

Manufacturers should pay particular attention to processing conditions. Since the intended functionality is linked to the preservation of the native structure, excessive heat or aggressive processing may be undesirable.

Supplier documentation should therefore clearly explain:

  • Manufacturing process
  • Temperature exposure
  • Drying process
  • Storage conditions
  • Structural integrity testing

4. Capsule and tablet development

Low-dose Type II collagen provides considerable flexibility for solid dosage formats.
However, formulators should evaluate:

  • Flow properties
  • Bulk density
  • Particle size
  • Excipient compatibility
  • Compression characteristics
  • Disintegration
  • Stability
  • Moisture sensitivity

The finished product should be tested rather than assuming that the raw ingredient’s characteristics will automatically translate into finished-product performance.

Why Clinical Evidence Matters to B2B Formulators

For nutraceutical brands, a clinically supported ingredient can provide an advantage when developing science-led products. However, clinical evidence should be interpreted carefully.

A study can tell a manufacturer:

  • What ingredient was tested
  • At what dose
  • For how long
  • In which population
  • Against which comparator
  • Which endpoints were evaluated
  • What outcomes were observed

It does not automatically validate every finished product containing that ingredient. For example, a 40 mg/day clinical study of a specific undenatured Type II collagen ingredient should not be used to claim that every Type II collagen product at 40 mg/day will deliver the same outcome.

For B2B communication, this level of scientific discipline builds credibility with R&D teams, regulatory professionals and technical buyers.

Products targeting active adults and healthy ageing can incorporate low-dose Type II collagen into daily joint-support formulations.

Active lifestyle

Joint mobility is relevant to consumers who engage in regular physical activity. Combination formulations can be developed around mobility and musculoskeletal support.

Osteoarthritis-focused products

The strongest clinical evidence is currently concentrated around knee osteoarthritis, although the appropriate regulatory positioning will vary by market.

Combination joint formulas

Type II collagen can also serve as a component of multi-ingredient formulations alongside established joint health ingredients. For manufacturers, the product concept should determine the ingredient combination rather than combining ingredients simply because they are associated with joint health.

Quality Control: What Should Be Included in the Undenatured Type II Collagen Technical Specification?

A B2B specification for undenatured chicken Type II collagen should ideally address:

Parameter Importance
Source Raw-material traceability
Collagen Type Confirms Type II identity
Undenatured status Central to intended functionality
Protein content Basic compositional specification
Purity Ingredient consistency
Structural integrity Relevant to biological activity
Moisture Stability and storage
Microbiology Product safety
Heavy metals Regulatory compliance
Allergen information Finished-product formulation
Batch consistency Commercial reproducibility
Shelf life Supply-chain planning
Storage conditions Product stability
Clinical documentation Evidence-based positioning

Buyers sourcing undenatured Type II collagen powder in bulk from India, or importing from an undenatured Type II collagen manufacturer and exporter, can use this table as a supplier approval sheet and request each item from the supplier before placing a commercial order. The exact specification should be adapted to the destination market and finished-product category.

The B2B Opportunity for Undenatured Type II Collagen

The growth of evidence-based joint health products creates an opportunity for manufacturers to move beyond conventional high-dose formulations.

Undenatured Type II collagen offers a differentiated ingredient proposition based on: Low-dose formulation, native Type II collagen, oral tolerance mechanism, clinical investigation and flexible solid dosage formats

For ingredient suppliers, the opportunity goes beyond supplying a powder.

Technical buyers increasingly require:

  • Clinical evidence
  • Consistent specifications
  • Manufacturing transparency
  • Regulatory documentation
  • Application support
  • Stability information
  • Batch-to-batch consistency

An ingredient supported by these elements can help nutraceutical brands develop more scientifically differentiated joint health products.

Conclusion: Undenatured Type II Collagen for Joint Health Supplements

Undenatured Type II collagen occupies a distinct position within the joint health ingredient category. Unlike hydrolysed collagen peptides, its proposed biological activity is associated with the preservation of native Type II collagen characteristics and the induction of oral tolerance.

Preclinical research supports this mechanism, while randomized clinical studies have investigated low-dose supplementation for knee osteoarthritis and joint function.

The 40 mg/day dose has been investigated in multiple clinical studies, including the 180-day multicenter trial and the 90-day Unstergen® clinical study.

For B2B manufacturers, however, dosage is only one part of the equation. The more important considerations are:

Native structure, ingredient identity, structural integrity, clinical evidence, dosage, formulation compatibility, batch consistency and regulatory documentation.When these factors are evaluated together, undenatured Type II collagen can offer nutraceutical developers a differentiated approach to joint health formulation.

That is the foundation for developing credible, science-led joint health products.
For nutraceutical brands, supplement companies and contract manufacturers looking for a dependable undenatured Type II collagen manufacturer and supplier, Titan Biotech Ltd. offers Unstergen® undenatured chicken collagen Type II for bulk supply and export from India. To request a specification sheet, COA, clinical documentation or quotation for undenatured Type II collagen for joint health supplements, send an enquiry to our team.

About Titan Biotech Ltd.: Undenatured Type II Collagen Manufacturer and Exporter

Titan Biotech Ltd. is a manufacturer and exporter of biological raw material ingredients based in Delhi, India. The company produces collagen, proteins, ox bile extracts, chelated minerals and botanical extracts for pharmaceutical, nutraceutical, cosmetic, animal nutrition, veterinary, food and beverage and biotechnology industries, and supplies customers in more than 100 countries.

As an undenatured Type II collagen manufacturer, supplier and exporter, Titan Biotech Ltd. offers Unstergen®, an undenatured chicken collagen Type II ingredient derived from chicken sternum cartilage and manufactured in GMP-certified facilities in India. Unstergen® was evaluated in a 90 day randomized, double-blind, placebo-controlled study at 40 mg/day in adults with osteoarthritis. Titan Biotech Ltd. works with B2B buyers in India and global markets, including nutraceutical brands, supplement companies and contract manufacturers. Alongside Unstergen®, the company supplies Titagen® hydrolysed fish collagen peptides.

Frequently Asked Questions About Undenatured Type II Collagen

Q1. What is undenatured Type II collagen?

Undenatured Type II collagen is collagen that has been processed to preserve important characteristics of its native structure. It is commonly sourced from chicken cartilage and is primarily investigated for joint health applications.

Q2. How is undenatured Type II collagen different from hydrolysed collagen?

Hydrolysed collagen is broken down into smaller peptides, whereas undenatured Type II collagen is intended to retain its native structural characteristics. Their proposed mechanisms, formulation approaches and typical dosages are therefore different.

Q3. What is the clinically studied dosage of undenatured Type II collagen?

A dose of 40 mg/day has been investigated in several clinical studies of undenatured Type II collagen, including a 180-day randomized trial and the 90-day Unstergen® clinical study.

Q4. How does undenatured Type II collagen work?

Its proposed mechanism involves oral tolerance. Type II collagen may interact with immune cells in the gut-associated lymphoid tissue and promote regulatory immune responses involving regulatory T cells and cytokines such as IL-10 and TGF-β.

Q5. Why is maintaining the undenatured structure important?

The proposed mechanism depends on structural features of Type II collagen. Processing that substantially alters the native structure may affect the biological characteristics relevant to oral tolerance.

Q6. Can undenatured Type II collagen be combined with glucosamine and chondroitin?

It can be formulated alongside other joint health ingredients, but compatibility, dosage, stability and the evidence supporting the finished formulation should be evaluated before making combination claims.

Q7. What dosage form is suitable for undenatured Type II collagen?

Because it is typically used at a relatively low dose, it can be suitable for capsules, tablets, sachets and other solid nutraceutical formats. The final dosage form should be optimized according to excipient compatibility and manufacturing requirements.

Q8. What should nutraceutical manufacturers ask a Type II collagen supplier?

Manufacturers should request information on source, Type II identity, undenatured status, structural integrity, purity, microbiological quality, heavy metals, batch consistency, stability, regulatory documentation and clinical evidence.

Q9. Is there clinical evidence for Unstergen® specifically?

Yes. A 2025 randomized, double-blind, placebo-controlled proof-of-concept study evaluated Unstergen® at 40 mg/day for 90 days in 48 adults with osteoarthritis. The study reported improvements in WOMAC, pain, quality of life and an X-ray-based outcome in a small subgroup.

Q10. Where can manufacturers read the Unstergen® clinical study?

The complete paper is available through the International Journal of Research in Orthopaedics:

Unstergen® Clinical Study in the International Journal of Research in Orthopaedics

Q11. Who is a reliable undenatured Type II collagen manufacturer in India?

Titan Biotech Ltd., based in Delhi, is manufacturer and exporter of biological raw material ingredients and the maker of Unstergen®. The company supplies customers in more than 100 countries, serving nutraceutical brands in India and international markets. Learn more about Titan Biotech Ltd..

Q12. How can I request a sample or quotation for undenatured Type II collagen?

Contact Titan Biotech Ltd. through the enquiry page, by email at info@titanbiotechltd.com or by phone at +91 97111 69006. Mention your dosage form, target market, required quantity and documentation so the team can respond with the right specification and quote.

About Titan Biotech Ltd.: Undenatured Type II Collagen Manufacturer and Exporter

Titan Biotech Ltd. is a manufacturer and exporter of biological raw material ingredients based in Delhi, India. The company produces collagen, proteins, ox bile extracts, chelated minerals and botanical extracts for pharmaceutical, nutraceutical, cosmetic, animal nutrition, veterinary, food and beverage and biotechnology industries, and supplies customers in more than 100 countries.

As an undenatured Type II collagen manufacturer, supplier and exporter, Titan Biotech Ltd. offers Unstergen®, an undenatured chicken collagen Type II ingredient derived from chicken sternum cartilage and manufactured in GMP-certified facilities in India. Unstergen® was evaluated in a 90 day randomized, double-blind, placebo-controlled study at 40 mg/day in adults with osteoarthritis. Titan Biotech Ltd. works with B2B buyers in India and global markets, including nutraceutical brands, supplement companies and contract manufacturers. Alongside Unstergen®, the company supplies Titagen® hydrolysed fish collagen peptides.